ESC Premium Access

Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in diabetics with cardiovascular disease or risk: a systematic review and meta-analysis of 13,395 patients

Topic: Diabetes, dysglycaemia and metabolic syndrome

Congress Presentation

About the speaker

Doctor Sean Zheng

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
1 follower

6 more presentations in this session

Use of insulin providers versus insulin sensitizers and risk of out-of-hospital cardiac arrest - a nationwide case-time-control study

Speaker: Mr G. Hognason Mohr (Copenhagen, DK)


Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial

Speaker: Doctor T. Aung (Oxford, GB)


Detailed description of myocardial infarctions and the various subtypes in the LEADER trial

Speaker: Professor M. Nauck (Bochum, DE)


Diabetes risk assessment of cardiovascular free individuals, through the calculation and evaluation of a lifestyle index; results of the 10-year follow up of the ATTICA study.

Speaker: Professor D. Panagiotakos (Athens, GR)


Genome-wide DNA methylation analysis for type 2 diabetes mellitus and cardiovascular disease: from a 23-Year follow-up in the Da Qing Diabetes Prevention Study


Access the full session

Diabetes mellitus: from "omics to complications"

Speakers: Doctor S. Zheng, Mr G. Hognason Mohr, Doctor T. Aung, Professor M. Nauck, Professor D. Panagiotakos

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb